Results 81 - 90 of 719 : Previous 5 6 7 8 9 10 11 12 13 Next
This Just In: More Upgrades and Downgrades
Leerink Swann dives into Lilly.
The Race: FDA Approval or Buyout?
Amarin moves closer to both.
The FTSE's Best Share Just Got Better
If business is so challenging for AstraZeneca, why is it raising forecasts and promising cash back?
Here's How Teva Pharmaceutical Industries May Be Failing You
Keep your eye on margins.
Teva Pharmaceutical Industries Passes This Key Test
Look here for a clue.
Don't just count the cash, time it.
Does Eli Lilly Miss the Grade?
Keep your eye on margins.
Bristol-Myers' Acquisition Could Pay for Itself
It will gain access to potential milestones.
This Just In: More Upgrades and Downgrades
Bank of America blasts AstraZeneca.
Could Eli Lilly's Stock Double Your Money?
With concerns swirling around the big pharma companies, could it be time to buy Eli Lilly?
Results 81 - 90 of 719 : Previous 5 6 7 8 9 10 11 12 13 Next